🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Qing Yang

ORCID: 0000-0001-8270-9643
Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Cell membrane-anchored and tumor-targeted IL-12 (attIL12)-T cell therapy for eliminating large and heterogeneous solid tumors”.

Cell membrane-anchored and tumor-targeted IL-12 (attIL12)-T cell therapy for eliminating large and heterogeneous solid tumors

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2021-003633
N/A
0DataRank · unranked
55 citations

Qing Yang, Wendong Zhang, Hongwei Du, Yu‐Hui Chen, Qingnan Zhao +10 more

Membrane-Anchored and Tumor-Targeted IL12 (attIL12)-PBMC Therapy for Osteosarcoma

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-0721
N/A
0DataRank · unranked
16 citations

Jiemiao Hu, Zhiliang Jia, Qi Wang, Jing Wang, Long Hoang Dao +6 more

Membrane-anchored and tumor-targeted Il-12(attIL12) PBMC therapy for osteosarcoma

Research Square(2022)10.21203/rs.3.rs-1392663/v1
N/A
0DataRank · unranked
1 citations

Jiemiao Hu, Zhiliang Jia, Qi Wang, Jing Wang, LongHoang Dao +5 more

Data from Membrane-Anchored and Tumor-Targeted IL12 (attIL12)-PBMC Therapy for Osteosarcoma

(2023)10.1158/1078-0432.c.6532343.v1
N/A
0DataRank · unranked
0 citations

Jiemiao Hu, Zhiliang Jia, Qi Wang, Jing Wang, Long Dao +6 more

Data from Membrane-Anchored and Tumor-Targeted IL12 (attIL12)-PBMC Therapy for Osteosarcoma

(2023)10.1158/1078-0432.c.6532343
N/A
0DataRank · unranked
0 citations

Jiemiao Hu, Zhiliang Jia, Qi Wang, Jing Wang, Long Dao +6 more